Oxford Biomedica Plc Stock Total Debt
| OXBDF Stock | USD 2.62 0.01 0.38% |
Oxford Biomedica plc fundamentals help investors to digest information that contributes to Oxford Biomedica's financial success or failures. It also enables traders to predict the movement of Oxford Pink Sheet. The fundamental analysis module provides a way to measure Oxford Biomedica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oxford Biomedica pink sheet.
Oxford |
Oxford Biomedica plc Company Total Debt Analysis
Oxford Biomedica's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Oxford Biomedica Total Debt | 107.5 M |
Most of Oxford Biomedica's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oxford Biomedica plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Based on the latest financial disclosure, Oxford Biomedica plc has a Total Debt of 107.5 M. This is 96.09% lower than that of the Healthcare sector and 66.9% lower than that of the Biotechnology industry. The total debt for all United States stocks is 97.98% higher than that of the company.
Oxford Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Oxford Biomedica's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Oxford Biomedica could also be used in its relative valuation, which is a method of valuing Oxford Biomedica by comparing valuation metrics of similar companies.Oxford Biomedica is currently under evaluation in total debt category among related companies.
Oxford Fundamentals
| Return On Equity | -0.14 | |||
| Return On Asset | -0.024 | |||
| Profit Margin | (0.20) % | |||
| Operating Margin | (0.10) % | |||
| Current Valuation | 436.12 M | |||
| Shares Outstanding | 96.27 M | |||
| Shares Owned By Insiders | 6.19 % | |||
| Shares Owned By Institutions | 62.89 % | |||
| Price To Earning | 17.67 X | |||
| Price To Book | 1.69 X | |||
| Price To Sales | 3.60 X | |||
| Revenue | 142.8 M | |||
| Gross Profit | 82.64 M | |||
| EBITDA | 33.22 M | |||
| Net Income | 19.01 M | |||
| Cash And Equivalents | 118.55 M | |||
| Cash Per Share | 1.23 X | |||
| Total Debt | 107.5 M | |||
| Debt To Equity | 0.41 % | |||
| Current Ratio | 1.83 X | |||
| Book Value Per Share | 2.31 X | |||
| Cash Flow From Operations | 25.45 M | |||
| Earnings Per Share | 0.24 X | |||
| Number Of Employees | 959 | |||
| Beta | 0.97 | |||
| Market Capitalization | 548.76 M | |||
| Total Asset | 237.23 M | |||
| Working Capital | 12.54 M | |||
| Current Asset | 25.71 M | |||
| Current Liabilities | 13.17 M | |||
| Z Score | 3.0 | |||
| Net Asset | 237.23 M |
About Oxford Biomedica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Oxford Biomedica plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oxford Biomedica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oxford Biomedica plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Oxford Biomedica in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Oxford Biomedica's short interest history, or implied volatility extrapolated from Oxford Biomedica options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oxford Biomedica plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Oxford Biomedica plc information on this page should be used as a complementary analysis to other Oxford Biomedica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Oxford Pink Sheet analysis
When running Oxford Biomedica's price analysis, check to measure Oxford Biomedica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oxford Biomedica is operating at the current time. Most of Oxford Biomedica's value examination focuses on studying past and present price action to predict the probability of Oxford Biomedica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oxford Biomedica's price. Additionally, you may evaluate how the addition of Oxford Biomedica to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |